294 related articles for article (PubMed ID: 10196927)
1. Hepatitis B vaccine as a cause of false positive hepatitis B surface antigen.
Olde C; Garcia M
J CANNT; 1998; 8(4):20-1. PubMed ID: 10196927
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B surface antigenemia following recombinant Engerix B hepatitis B vaccine in an 81-year-old ESRD patient on hemodialysis.
Onuigbo MA; Nesbit A; Weisenbeck J; Hurlburt J
Ren Fail; 2010 May; 32(4):531-2. PubMed ID: 20446799
[TBL] [Abstract][Full Text] [Related]
3. [Transient blood surface antigens of hepatitis B in patients on hemodialysis].
Santana Rodríguez OE; Morillas Jarillo C; Esparza Martín N; Toledo González A; Checa Andrés MD; Martín Sánchez AM
Rev Clin Esp; 1999 Apr; 199(4):198-201. PubMed ID: 10364790
[TBL] [Abstract][Full Text] [Related]
4. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
5. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
6. Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers.
Poovorawan Y; Chongsrisawat V; Theamboonlers A; Srinivasa K; Hutagalung Y; Bock HL; Hoet B
J Infect Dis; 2009 Jul; 200(1):33-8. PubMed ID: 19473096
[TBL] [Abstract][Full Text] [Related]
7. [Prevention and treatment of hepatitis B in patients on hemodialysis and vaccination of hemodialysis health personnel against hepatitis B].
Kes P; Slavicek J; Janković N
Acta Med Croatica; 2005; 59(5):479-82. PubMed ID: 16381247
[TBL] [Abstract][Full Text] [Related]
8. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
[TBL] [Abstract][Full Text] [Related]
10. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
11. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
[TBL] [Abstract][Full Text] [Related]
12. Emergence of hepatitis B infection despite antibodies to hepatitis B surface antigen: a new nosocomial risk in patients with end-stage renal disease.
Moal V; Vacher-Coponat H; Botelho E; Berland Y; Colson P; Tamalet C; Henry M
Transplantation; 2006 May; 81(9):1358-9. PubMed ID: 16699469
[No Abstract] [Full Text] [Related]
13. [Infections with hepatitis B virus in hemodialysis units of Wielkopolska].
Grzegorzewska AE; Kurzawska-Firlej D; Swiderski A; de Mezer-Dambek M; Frankiewicz D; Zaremba-Drobnik D; Banachowicz W; Dumanowska-Zmuda A; Ratajewski W; Niepolski L; Krawczyk R; Sobolewski J; Pulchny J; Molenda J; Wojciechowski J; Mikstacki Z; Zachwieja J
Przegl Epidemiol; 2008; 62(1):29-37. PubMed ID: 18536222
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria.
Odusanya OO; Alufohai FE; Meurice FP; Wellens R; Weil J; Ahonkhai VI
Int J Infect Dis; 2005 May; 9(3):139-43. PubMed ID: 15840454
[TBL] [Abstract][Full Text] [Related]
15. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
[TBL] [Abstract][Full Text] [Related]
16. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
17. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
Krishnamurthy G; Kher V; Naik S
Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
[TBL] [Abstract][Full Text] [Related]
18. [Vaccination against hepatitis virus B infection. Vaccine from inactivated HBsAg positive plasma or recombinant vaccine?].
Horejsí J
Cas Lek Cesk; 1987 Jul; 126(31):981-2. PubMed ID: 2959363
[No Abstract] [Full Text] [Related]
19. [Surveillance in children of mothers positive to hepatitis B surface antigen, 2000-2002].
Bello Corredor M; Rodriguez Lay Lde L; Delgado González G; Diaz González M; Montalvo Villar MC; Gutiérrez Moreno A
Rev Cubana Med Trop; 2004; 56(1):31-4. PubMed ID: 15849906
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
